Biomea Fusion, Inc. (BMEA)
USD 1.95
(-9.72%)
USD 1.95
(-9.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 4.2 Million | 1.26 Million | 953 Thousand | 132 Thousand | - |
| Gross Profit | -4.2 Million | -1.26 Million | -953 Thousand | -132 Thousand | - |
| Operating Expenses | 126.13 Million | 83.63 Million | 41.66 Million | 5.32 Million | 1.19 Million |
| Selling, General and Administrative Expenses | 23.58 Million | 20.92 Million | 13.67 Million | 1.65 Million | 103 Thousand |
| Research and Development Expenses | 102.54 Million | 62.71 Million | 27.99 Million | 3.67 Million | 1.09 Million |
| Other Expenses | - | - | - | 3000.00 | -3000.00 |
| Cost and Expenses | 126.13 Million | 83.63 Million | 41.66 Million | 5.32 Million | 1.19 Million |
| Operating Income | -126.13 Million | -83.63 Million | -41.66 Million | -5.32 Million | -1.19 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | - | -1.8 Million | -349 Thousand | -198.29 Thousand | -1195.00 |
| Earnings before Tax | -117.25 Million | -81.82 Million | -41.56 Million | -5.32 Million | -1.19 Million |
| Net Income | -117.25 Million | -80.02 Million | -41.21 Million | -5.32 Million | -1.19 Million |
| Earnings Per Share Basic | -3.44 | -2.73 | -1.73 | -0.50 | -0.11 |
| Earnings Per Share Diluted | -3.44 | -2.73 | -1.73 | -0.50 | -0.11 |
| Weighted Average Shares Outstanding | 34.1 Million | 29.27 Million | 23.85 Million | 10.7 Million | 10.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.1 Million | 29.27 Million | 23.85 Million | 10.7 Million | 10.7 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -124.62 Million | -82.94 Million | -41.41 Million | -5.31 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 6.14 Million | - |
| Cost of Revenue | 400 Thousand | 400 Thousand | 420 Thousand | 4.2 Million | 1.13 Million | 1.11 Million |
| Gross Profit | -400 Thousand | -400 Thousand | -420 Thousand | -4.2 Million | 5.01 Million | -1.11 Million |
| Operating Expenses | 34.03 Million | 38.49 Million | 40.63 Million | 121.93 Million | 36.19 Million | 31.11 Million |
| Selling, General and Administrative Expenses | 6.79 Million | 6.67 Million | 6.86 Million | - | 5.33 Million | 5.77 Million |
| Research and Development Expenses | 27.24 Million | 31.82 Million | 33.77 Million | - | 30.86 Million | 25.34 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 34.03 Million | 38.89 Million | 41.05 Million | 126.13 Million | 37.32 Million | 31.11 Million |
| Operating Income | -34.03 Million | -38.89 Million | -41.05 Million | -126.13 Million | -37.32 Million | -31.11 Million |
| Interest Expense | - | - | - | - | 980 Thousand | - |
| Income Tax Expense | -400 Thousand | - | 376.72 Thousand | - | 1.78 Million | -419 Thousand |
| Earnings before Tax | -32.78 Million | -37.27 Million | -39.06 Million | -117.25 Million | -34.88 Million | -28.42 Million |
| Net Income | -32.78 Million | -37.27 Million | -39.06 Million | -117.25 Million | -34.88 Million | -28.42 Million |
| Earnings Per Share Basic | -0.91 | -1.03 | -1.09 | - | -0.97 | -0.80 |
| Earnings Per Share Diluted | -0.91 | -1.03 | -1.09 | - | -0.97 | -0.80 |
| Weighted Average Shares Outstanding | 36.22 Million | 36.04 Million | 35.89 Million | 34.1 Million | 35.86 Million | 35.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.22 Million | 36.04 Million | 35.89 Million | 34.1 Million | 35.86 Million | 35.65 Million |
| Gross Margin | - | - | - | - | 0.82 | - |
| EBIT Margin | - | - | - | - | -5.89 | - |
| Profit Margin | - | - | - | - | -5.68 | - |
| EBITDA | -34.03 Million | -38.49 Million | -40.63 Million | - | -36.19 Million | -31.11 Million |
| Earnings Before Tax Margin | - | - | - | - | -6.08 | - |
RRX
TRT
KNSA
SCM
1682
FFIV